Login / Signup

Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol.

Elsa TavernierFrancois BarbierFerhat MezianiJean-Pierre QuenotJean-Etienne HerbrechtMickael LandaisDamien RouxPhilippe SeguinDavid SchnellAnne VeinsteinBenoît VeberSigismond LasockiQin LuGaetan BeduneauMartine FerrandiereClaire Dahyot-FizelierGaetan PlantefeveMai-Anh NayHamid MerdjiPascal AndreuLaurent VecellioGrégoire MullerMaria CabreraDeborah Le PennecRenaud RespaudPhilippe LanotteNicolas GregoireMarie LeclercJulie HelmsThierry BoulainJean-Claude LacheradeStephan Ehrmannnull null
Published in: BMJ open (2021)
EudraCT 2016-001054-17 and NCT03149640.
Keyphrases
  • double blind
  • study protocol
  • placebo controlled
  • randomized controlled trial
  • clinical trial
  • phase iii
  • cystic fibrosis
  • phase ii
  • open label
  • community acquired pneumonia